Literature DB >> 11978509

Distinction between familial and sporadic forms of colorectal cancer showing DNA microsatellite instability.

J R Jass1, M D Walsh, M Barker, L A Simms, J Young, B A Leggett.   

Abstract

Attempts to classify colorectal cancer into subtypes based upon molecular characterisation are overshadowed by the classical stepwise model in which the adenoma-carcinoma sequence serves as the morphological counterpart. Clarity is achieved when cancers showing DNA microsatellite instability (MSI) are distinguished as sporadic MSI-low (MSI-L), sporadic MSI-high (MSI-H) and hereditary non-polyposis colorectal cancer (HNPCC). Divergence of the 'methylator' pathway into MSI-L and MSI-H is at least partly determined by the respective silencing of MGMT and hMLH1. Multiple differences can be demonstrated between sporadic and familial (HNPCC) MSI-H colorectal cancer with respect to early mechanisms, evolution, molecular characterisation, demographics and morphology. By acknowledging the existence of multiple pathways, rapid advances in the fields of basic and translational research will occur and this will lead to improved strategies for the prevention, early detection and treatment of colorectal cancer.

Entities:  

Mesh:

Year:  2002        PMID: 11978509     DOI: 10.1016/s0959-8049(02)00041-2

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  38 in total

1.  BRAF mutation and gene methylation frequencies of colorectal tumours with microsatellite instability increase markedly with patient age.

Authors:  B Iacopetta; W Q Li; F Grieu; A Ruszkiewicz; K Kawakami
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

2.  Differential clinicopathological features in microsatellite instability-positive colorectal cancers depending on CIMP status.

Authors:  Jeong Mo Bae; Mi Jung Kim; Jung Ho Kim; Jae Moon Koh; Nam-Yun Cho; Tae-You Kim; Gyeong Hoon Kang
Journal:  Virchows Arch       Date:  2011-04-15       Impact factor: 4.064

3.  Clinicopathologic and molecular features of sporadic microsatellite- and chromosomal-stable colorectal cancers.

Authors:  Guoxiang Cai; Ye Xu; Hongfen Lu; Yingqiang Shi; Peng Lian; Junjie Peng; Xiang Du; Xiaoyan Zhou; Zuqing Guan; Daren Shi; Sanjun Cai
Journal:  Int J Colorectal Dis       Date:  2008-04       Impact factor: 2.571

4.  Selection of patients with germline MLH1 mutated Lynch syndrome by determination of MLH1 methylation and BRAF mutation.

Authors:  Hanifa Bouzourene; Pierre Hutter; Lorena Losi; Patricia Martin; Jean Benhattar
Journal:  Fam Cancer       Date:  2010-06       Impact factor: 2.375

Review 5.  Microsatellite instability in gastrointestinal tract cancers: a brief update.

Authors:  Shinya Oda; Yan Zhao; Yoshihiko Maehara
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

6.  Increased Incidence of Second Primary Pancreatic Cancer in Patients with Prior Colorectal Cancer: A Population-Based US Study.

Authors:  Erik Rahimi; Sachin Batra; Nirav Thosani; Harminder Singh; Sushovan Guha
Journal:  Dig Dis Sci       Date:  2016-04-23       Impact factor: 3.199

Review 7.  Clinical description of the Lynch syndrome [hereditary nonpolyposis colorectal cancer (HNPCC)].

Authors:  H F A Vasen
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

8.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.

Authors:  Asad Umar; C Richard Boland; Jonathan P Terdiman; Sapna Syngal; Albert de la Chapelle; Josef Rüschoff; Richard Fishel; Noralane M Lindor; Lawrence J Burgart; Richard Hamelin; Stanley R Hamilton; Robert A Hiatt; Jeremy Jass; Annika Lindblom; Henry T Lynch; Païvi Peltomaki; Scott D Ramsey; Miguel A Rodriguez-Bigas; Hans F A Vasen; Ernest T Hawk; J Carl Barrett; Andrew N Freedman; Sudhir Srivastava
Journal:  J Natl Cancer Inst       Date:  2004-02-18       Impact factor: 13.506

9.  Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer.

Authors:  M B Loughrey; P M Waring; A Tan; M Trivett; S Kovalenko; V Beshay; M-A Young; G McArthur; A Boussioutas; A Dobrovic
Journal:  Fam Cancer       Date:  2007-04-24       Impact factor: 2.375

10.  Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer.

Authors:  A McGivern; C V A Wynter; V L J Whitehall; T Kambara; K J Spring; M D Walsh; M A Barker; S Arnold; L A Simms; B A Leggett; J Young; J R Jass
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.